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SUMMARY 
Sucrose Acetate IsoButyrate (SAIB)-based radiopaque 
fiducial tissue markers containing coated gold 
nanoparticles (AuNPs) have been developed. One of these 
formulations, the PNIPAM (poly(N-isopropyl 
acrylamide))-AuNP-SAIB based gel, was assessed to be a 
suitable marker for image guided radiotherapy (IGRT). 
 
INTRODUCTION 
IGRT is an important tool used to visualize tumors during 
radiation treatment. Tumors rarely display a fixed position 
during irradiation or within a treatment period due to 
breathing motion, changes in organ filling and tumor size. 
Radiopaque fiducial tissue markers are therefore of great 
interest to place within - or around tumors in order to 
achieve high precision in IGRT. Better markers will 
enable improved tumor coverage i.e. the destruction of all 
cancer tissue. Furthermore, it is important to have a safer 
and more accurate setup for tumor treatment in 
radiotherapy - including adaptation of online “tumor-
tracking” – thereby delivering high radiation doses to 
tumors with minimal damage to surrounding healthy 
tissue [1].  
 
EXPERIMENTAL METHODS 
The poster presents the development of novel injectable 
liquid fiducial markers based on formulations of SAIB 
and polylactide (PLA) containing coated AuNPs. A 
mixture of SAIB/EtOH/PLA (75:20:5) was used as matrix 
due to its high biocompatibility, low viscosity, as well as 
its ability to form a stable, biodegradable gel depot upon 
injection [2]. Three different AuNP coating systems were 
tested – a dithiolane functionalized SAIB derivative, 
synthesized in four steps starting from sucrose, together 
with PEG- and PNIPAM polymers, respectively. The 
AuNPs were synthesized by a three step seeding protocol 
using chloroauric acid as Au3+ source and trisodium 
citrate as reductant and stabilizer. In vitro release from 
SAIB gels was studied in PBS-buffer at 370C. Gels 
(200µL) containing SAIB/EtOH/PLA (75:20:5) + 30mg 
PNIPAM-AuNPs mL-1 or 10mg PEG-AuNPs mL-1 were 
injected subcutaneously at the upper left flank of 
immunocompetent NMRI-mice using hypodermic 25G 
needles. The gel-depots were visualized by micro-CT 
imaging.  
 
RESULTS AND DISCUSSION 
The dithiolane functionalized SAIB derivative was 
discarded as a coating option due to irreversible 
aggregation of the formed nanoparticles. The SAIB gels 
containing PEGylated AuNPs provided high CT contrast 
in vivo, however it suffered from AuNP migration 
towards the gel-boundaries resulting in an inhomogeneous 
distribution of contrast agent. The PNIPAM-coated-
AuNP-SAIB gel provided both excellent CT contrast and 
high in vivo stability. Furthermore, the PNIPAM-coated-
AuNPs are easy to handle, as they can be lyophilized and 
stored as an air stable powder, which is readily dispersible 
in ethanol.  
 
 
Maximum Intensity Projection of PNIPAM-AuNP-SAIB 
gel depot in a mouse viewed from several angles. 
 
CONCLUSION 
The PNIPAM-AuNP-SAIB gel showed high stability, 
biocompatibility and provided high CT contrast in vivo. 
This gel is a viable alternative to existing liquid fiducial 
markers.  
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